ABOUT NOVIAN HEALTH
Novian Health Inc., based in Chicago, IL, is a privately held company with proprietary technology for the treatment of tumors using Novilase Interstitial Laser Therapy (ILT). Novian Health SAS, is a wholly owned subsidiary, based in France that leads the company’s research and development efforts in Europe. The company has developed, tested, and patented a minimally-invasive procedure, Novilase, that uses laser therapy (controlled heating) for the ablation of breast tumors as an alternative to lumpectomy.
Novilase offers significant advantages over surgical removal, including minimal scarring, quicker recovery times, and the use of local anesthesia. Novian Health has received FDA 510(k) market clearance for the treatment of benign tumors of the breast and Novilase is available at select breast centers in the United States.
Novian Health’s proprietary technology enables surgeons and radiologists to ablate tumors with image-guided interstitial laser therapy as a minimally invasive alternative to surgery. The company was founded by Dr. Kambiz Dowlat a former professor of surgery at Rush University Medical Center who has specialized in breast cancer diagnosis and treatment for 25 years.
The mission of Novian Health is to be the leading company in image-guided laser tumor therapy. The vision is to establish laser therapy as an enabling technology, leveraging the advances in diagnostic detection technologies, to allow the treatment of smaller tumors at earlier stages for the benefit of the patient, without invasive surgery and the attendant trauma or cost. For more information, visit www.novianhealth.com.
Novian Health Inc.
430 West Erie Street, Suite 500
Chicago, Illinois 60654
Novian Health SAS
Pepiniere Genopole Enterprise Campus
1 rue Pierre Fontaine 91058